Yesterday it had a small morning spike then dropped 35c. I do not expect it to spike very much but it could end up consolidating like it did before in the $12.50 - $12.80 range.
Not much volume premarket at the moment. Yesterday it sold off during premarket then managed to spike during the day. Daily chart looks pretty bad now. Multiday breakout over $6.05.
- Celsion (CLSN) Announces Final Clinical, Translational Research Data from OVATION Study at AACR (Earlier)
Big spike into the close yesterday on news. Possible resistance at $3.00 and $3.50.
- Streamline Health® Expands Relationship With Existing Audit Services Client By Adding eValuator™ Automated Pre-Bill Auditing Software
Still watching this after a few days. It’s been very choppy every day so I’m not that comfortable buying it.
- Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted Radioligand Therapy for Development in Prostate Cancer
Morning spike yesterday then cracked and sort of faded all day long. We’ll have to see what it does today.
This stock was hot a few weeks ago and is spiking again. There is an offering at $4/share so I’m wondering if it will drop because of that. There are 159K shares available in IB at the moment. I suppose the offering price isn’t that far off from yesterday’s close. If it had been done at a huge discount like 50% to 75% it would crash. Huge discounts mean they are desparate for cash.
Float is a bit higher so it might not move as much as the others. Possible resistance at $7.20, $7.50, and $7.70. Yearly chart looks very choppy to me.
Today just feels kind of slow compared to the past few. Most of the stocks on my list had failed morning spikes that faded. $APVO is the only one I’m seeing that had a good sized spike before coming down. $INO crashed right out of the gate. $MNKD was decent but I wasn’t really watching it.
I am not a registered financial adviser/broker/anything. Use this information for entertainment/informational purposes only. Any tickers mentioned are not recommendations to buy/sell/or sell short. They are used as examples only.